Tags

Type your tag names separated by a space and hit enter

Non-invasive ventilation in the treatment of early hypoxemic respiratory failure caused by COVID-19: considering nasal CPAP as the first choice.
Crit Care. 2020 06 11; 24(1):333.CC

Links

PMC Free PDF

Authors+Show Affiliations

Guan L
State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.
Zhou L
State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.
Le Grange JM
Department of Emergency Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Zheng Z
State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.
Chen R
Department of Respiratory and Critical Care Medicine, First Affiliated Hospital of Southern University of Science and Technology, Second Clinical Medical College of Jinan University, Shenzhen People's Hospital, Shenzhen Institute of Respiratory Diseases, 1017 Dong Men Road, Shenzhen, 518020, China. chenrc@vip.163.com.

MeSH

Acute DiseaseBetacoronavirusCOVID-19Continuous Positive Airway PressureCoronavirus InfectionsHumansIntensive Care UnitsNoninvasive VentilationOxygen Inhalation TherapyPandemicsPneumonia, ViralRespiratory InsufficiencySARS-CoV-2

Pub Type(s)

Letter

Language

eng

PubMed ID

32527302

Citation

Guan, Lili, et al. "Non-invasive Ventilation in the Treatment of Early Hypoxemic Respiratory Failure Caused By COVID-19: Considering Nasal CPAP as the First Choice." Critical Care (London, England), vol. 24, no. 1, 2020, p. 333.
Guan L, Zhou L, Le Grange JM, et al. Non-invasive ventilation in the treatment of early hypoxemic respiratory failure caused by COVID-19: considering nasal CPAP as the first choice. Crit Care. 2020;24(1):333.
Guan, L., Zhou, L., Le Grange, J. M., Zheng, Z., & Chen, R. (2020). Non-invasive ventilation in the treatment of early hypoxemic respiratory failure caused by COVID-19: considering nasal CPAP as the first choice. Critical Care (London, England), 24(1), 333. https://doi.org/10.1186/s13054-020-03054-7
Guan L, et al. Non-invasive Ventilation in the Treatment of Early Hypoxemic Respiratory Failure Caused By COVID-19: Considering Nasal CPAP as the First Choice. Crit Care. 2020 06 11;24(1):333. PubMed PMID: 32527302.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Non-invasive ventilation in the treatment of early hypoxemic respiratory failure caused by COVID-19: considering nasal CPAP as the first choice. AU - Guan,Lili, AU - Zhou,Luqian, AU - Le Grange,Jehane Michael, AU - Zheng,Zeguang, AU - Chen,Rongchang, Y1 - 2020/06/11/ PY - 2020/05/26/received PY - 2020/06/02/accepted PY - 2020/6/13/entrez PY - 2020/6/13/pubmed PY - 2020/6/24/medline SP - 333 EP - 333 JF - Critical care (London, England) JO - Crit Care VL - 24 IS - 1 SN - 1466-609X UR - https://www.unboundmedicine.com/medline/citation/32527302/Non_invasive_ventilation_in_the_treatment_of_early_hypoxemic_respiratory_failure_caused_by_COVID_19:_considering_nasal_CPAP_as_the_first_choice_ DB - PRIME DP - Unbound Medicine ER -